»» Searching for " Apricus "
 Related Search Tags:  Apricus APRI Nasdaq:APRI Dexrazoxane
Showing Results 1-1 of 1 |  Sort by:     
Page 1 of 1  |  Go to page   
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. According to a a definitive agreement between the companies, Apricus Biosciences Inc - APRI - will acquire Topotarget USA, who owns Totect (Dexrazoxane HCl), the only drug approved by the FDA to treat a potentially serious complication of cancer therapy—the leakage of chemotherapy drugs from veins into surrounding tissues. This complication is known as anthracycline extravasation, and can lead to infections and tissue death. With this acquisition, Apricus Biosciences will move into the commercialization and sales of oncology and oncology supportive care pharmaceuticals. Apricus Biosciences is a revenue-generating, specialty pharmaceutical company, with commercial products and a broad pipeline across numerous therapeutic classes. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
Apricus Biosciences (APRI)...
Categories: Videos 
Added: 155 days ago
By: karmastock
Runtime: 1m21s
Views: 42
 | Comments: 0
Not yet rated
Page 1 of 1  |  Go to page   
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.0997 seconds.